Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ARCAGY/ GINECO GROUP
With
AstraZeneca
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients must be female ≥18 years of age
Patients with histologically confirmed ovarian cancer, primary peritoneal cancer and / or fallopian-tube cancer that were treated with olaparib in a real life-setting, between May 2014 to March 2017, whatever the line of therapy
Patients can be either alive or deceased at the time of medical record abstraction
Patients should not have any objection that anonymized data will be collected and subjected to automated processing.
You may not be if
Patient that were given olaparib within a clinical trial
Clareo Health | Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients
